Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Pulmonary Hypertension, April 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 160 articles:
HTML format


 

Single Articles

  1. GHIO S, D'Alto M, Badagliacca R, Vizza CD, et al
    Pulmonary hypertension in left heart disease: The need to continue to explore.
    Int J Cardiol. 2019 Mar 17. pii: S0167-5273(19)30571.
    Abstract    



  2. ATIK E, Barreto AC, Binotto MA
    Case 2 / 2019 - Complete Atrioventricular Septal Defect, with Down Syndrome, without Pulmonary Hypertension and Natural History at 33 Years of Age.
    Arq Bras Cardiol. 2019;112:319-320.
    Abstract    



  3. ZUCKER MM, Wujak L, Gungl A, Didiasova M, et al
    LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension.
    Biochim Biophys Acta Mol Basis Dis. 2019 Mar 22. pii: S0925-4439(19)30086.
    Abstract    

    Abstract available

  4. SHAHIN Y, Rothman AM
    Commentary on: evaluation of a newly developed 2D parametric parenchymal blood flow technique with an automated vessel suppression algorithm in patients with chronic thromboembolic pulmonary hypertension undergoing balloon pulmonary angioplasty.
    Clin Radiol. 2019 Mar 22. pii: S0009-9260(19)30122.
    Abstract    



  5. FUSO L, Pitocco D, Antonelli Incalzi R
    Diabetic lung, an underrated complication from restrictive functional pattern to pulmonary hypertension.
    Diabetes Metab Res Rev. 2019 Mar 25:e3159. doi: 10.1002/dmrr.3159.
    Abstract    

    Abstract available

  6. KATZ MG, Fargnoli AS, Gubara SM, Bisserier M, et al
    The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats.
    J Vis Exp. 2019;.
    Abstract    

    Abstract available

  7. EYUBOGLU M
    The complexity of pulmonary hypertension.
    Hemodial Int. 2019 Mar 24. doi: 10.1111/hdi.12755.
    Abstract    



  8. KROGER JR, Gerhardt F, Dumitrescu D, Rosenkranz S, et al
    Diagnosis of pulmonary hypertension using spectral-detector CT.
    Int J Cardiol. 2019 Mar 13. pii: S0167-5273(18)35867.
    Abstract    

    Abstract available

  9. MIYANAGA S, Kubota K, Iwatani N, Higo K, et al
    Predictors of exercise-induced pulmonary hypertension in patients with connective tissue disease.
    Heart Vessels. 2019 Mar 23. pii: 10.1007/s00380-019-01373.
    Abstract    

    Abstract available

  10. HAN H, Francis JK, Spitzer Y, Reddy S, et al
    Anesthetic management of parturients with pulmonary hypertension undergoing cesarean deliveries.
    J Clin Anesth. 2019;57:79.
    Abstract    



  11. WOO KV, Ornitz DM, Singh GK
    Diagnosis and Pathophysiological Mechanisms of Group 3 Hypoxia-Induced Pulmonary Hypertension.
    Curr Treat Options Cardiovasc Med. 2019;21:16.
    Abstract    

    Abstract available

  12. NEIVA J, Fernandes G, Carvalho D, Ferreira B, et al
    Thyroid storm and myxoedema: two reversible causes of acute heart failure.
    Acute Med. 2018;17:229-231.
    Abstract    

    Abstract available

  13. MATSUMOTO T, Tamiya E, Kanoh T, Takabe T, et al
    Atrial Septal Defect of the Ostium Secundum Type in A 101-Year-Old Patient.
    Int Heart J. 2019;60:489-491.
    Abstract    

    Abstract available

  14. MINATSUKI S, Takeda N, Soma K, Katoh M, et al
    Murine Model of Pulmonary Artery Overflow Vasculopathy Revealed Macrophage Accumulation in the Lung.
    Int Heart J. 2019;60:451-456.
    Abstract    

    Abstract available

  15. FUKUOKA K, Aizawa K, Sugaya A, Kawada M, et al
    [Idiopathic Pulmonary Artery Aneurysm].
    Kyobu Geka. 2018;71:1088-1091.
    Abstract    

    Abstract available

  16. GUNTHER S, Bordenave J, Hua-Huy T, Nicco C, et al
    Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis.
    Int J Mol Sci. 2018;19.
    Abstract    

    Abstract available

  17. SATOH K, Kikuchi N, Satoh T, Kurosawa R, et al
    Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2018;19.
    Abstract    

    Abstract available

  18. HUANG C, Yang J, Li MT, Wang Q, et al
    CBLN2 rs2217560 was Associated with Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus.
    Chin Med J (Engl). 2018;131:3020-3021.
    Abstract    



  19. AGGARWAL S, Shanti C, Lelli J, Natarajan G, et al
    Prognostic utility of noninvasive estimates of pulmonary vascular compliance in neonates with congenital diaphragmatic hernia.
    J Pediatr Surg. 2018 Sep 9. pii: S0022-3468(18)30565.
    Abstract    

    Abstract available

  20. DUAN L, Hu GH, Li YJ, Zhang CL, et al
    P2X7 receptor is involved in lung injuries induced by ischemia-reperfusion in pulmonary arterial hypertension rats.
    Mol Immunol. 2018;101:409-418.
    Abstract    

    Abstract available

  21. AGUERO J, Hammoudi N, Bikou O, Fish KM, et al
    Chronic Pulmonary Artery Embolization Models in Large Animals.
    Methods Mol Biol. 2018;1816:353-366.
    Abstract    

    Abstract available

  22. BUENO-BETI C, Hadri L, Hajjar RJ, Sassi Y, et al
    The Sugen 5416/Hypoxia Mouse Model of Pulmonary Arterial Hypertension.
    Methods Mol Biol. 2018;1816:243-252.
    Abstract    

    Abstract available

  23. BUENO-BETI C, Sassi Y, Hajjar RJ, Hadri L, et al
    Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration.
    Methods Mol Biol. 2018;1816:233-241.
    Abstract    

    Abstract available

  24. SANDNER P
    From molecules to patients: exploring the therapeutic role of soluble guanylate cyclase stimulators.
    Biol Chem. 2018;399:679-690.
    Abstract    

    Abstract available

  25. GOUMANS MJ, Zwijsen A, Ten Dijke P, Bailly S, et al
    Bone Morphogenetic Proteins in Vascular Homeostasis and Disease.
    Cold Spring Harb Perspect Biol. 2018;10.
    Abstract    

    Abstract available

  26. GOUMANS MJ, Ten Dijke P
    TGF-beta Signaling in Control of Cardiovascular Function.
    Cold Spring Harb Perspect Biol. 2018;10.
    Abstract    

    Abstract available

  27. HUDALLA H, Michael Z, Christodoulou N, Willis GR, et al
    Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2019 Apr 5. doi: 10.1165/rcmb.2018-0232.
    Abstract    

    Abstract available

  28. SHARMA A, Navalkele P, Desai J, Agarwal P, et al
    Hydrops Fetalis and Persistent Pulmonary Hypertension in a Neonate with Anti-E Alloimmunization.
    Case Rep Obstet Gynecol. 2019;2019:3736870.
    Abstract    

    Abstract available

  29. CHEN L, Wang N, Peng B, He W, et al
    Pulmonary Artery Denervation: An Alternative Therapy for Pulmonary Hypertension.
    JACC Cardiovasc Interv. 2019;12:691-692.
    Abstract    



  30. REN X, Johns RA, Gao WD
    EXPRESS: Right Heart in Pulmonary Hypertension: From Adaptation to Failure.
    Pulm Circ. 2019 Apr 3:2045894019845611. doi: 10.1177/2045894019845611.
    Abstract    



  31. ZHANG M, Zhang YX, Pang W, Zhai Z, et al
    EXPRESS: Circulating biomarkers in chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2019 Apr 3:2045894019844480. doi: 10.1177/2045894019844480.
    Abstract    



  32. RADCHENKO GG, Zhyvilo IO, Sirenko YM
    EXPRESS: ANALYSIS OF PULMONARY HYPERTENSION PATIENT SURVIVAL AFTER TREATMENT IN REFERRAL CENTER (DATA OF FIRST UKRAINIAN REGISTER).
    Pulm Circ. 2019 Apr 3:2045894019845604. doi: 10.1177/2045894019845604.
    Abstract    



  33. ZHU Z, Godana D, Li A, Rodriguez B, et al
    EXPRESS: Echocardiographic Assessment of Right Ventricular Functions in Experimental Pulmonary Hypertension.
    Pulm Circ. 2019 Apr 3:2045894019841987. doi: 10.1177/2045894019841987.
    Abstract    



  34. CERVI A, Douketis JD
    Prevalence of antiphospholipid antibodies among patients with chronic thromboembolic pulmonary hypertension.
    Intern Emerg Med. 2019 Apr 1. pii: 10.1007/s11739-019-02078.
    Abstract    



  35. BEHERE S, Alapati D, McCulloch MA
    Screening Echocardiography and Brain Natriuretic Peptide Levels Predict Late Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia.
    Pediatr Cardiol. 2019 Apr 1. pii: 10.1007/s00246-019-02100.
    Abstract    

    Abstract available

  36. MAGON W, Stepniewski J, Waligora M, Jonas K, et al
    Pulmonary Artery Elastic Properties After Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension.
    Can J Cardiol. 2019;35:422-429.
    Abstract    

    Abstract available

  37. ZHANG CF, Zhao FY, Xu SL, Liu J, et al
    Autophagy in pulmonary hypertension: Emerging roles and therapeutic implications.
    J Cell Physiol. 2019 Apr 1. doi: 10.1002/jcp.28531.
    Abstract    

    Abstract available

  38. HUSTON JH, Frantz R, Brittain E
    EXPRESS: Early Intervention: Should We Conduct Therapeutic Trials For Mild Pulmonary Hypertension Before Onset of Symptoms?
    Pulm Circ. 2019 Apr 1:2045894019844994. doi: 10.1177/2045894019844994.
    Abstract    



  39. HUR DJ, Sugeng L
    Non-invasive Multimodality Cardiovascular Imaging of the Right Heart and Pulmonary Circulation in Pulmonary Hypertension.
    Front Cardiovasc Med. 2019;6:24.
    Abstract    

    Abstract available

  40. CHEN ZW, Chen CW, Wu CK, Hsu HH, et al
    Balloon Pulmonary Angioplasty in Chronic Pulmonary Thromboembolic Pulmonary Hypertension.
    Acta Cardiol Sin. 2019;35:183-187.
    Abstract    



  41. CHEN YJ, Ho CT, Tsai FC, Lin CP, et al
    Outcomes of Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension at a Single Center in Taiwan.
    Acta Cardiol Sin. 2019;35:153-164.
    Abstract    

    Abstract available

  42. GOPAL DM, Ayalon N, Wang YC, Siwik D, et al
    Galectin-3 Is Associated With Stage B Metabolic Heart Disease and Pulmonary Hypertension in Young Obese Patients.
    J Am Heart Assoc. 2019;8:e011100.
    Abstract    

    Abstract available

  43. KOJIMA H, Tokunou T, Takahara Y, Sunagawa K, et al
    Hypoxia-inducible factor-1 alpha deletion in myeloid lineage attenuates hypoxia-induced pulmonary hypertension.
    Physiol Rep. 2019;7:e14025.
    Abstract    

    Abstract available

  44. YIN TJ, Hu YS, Cheng S, Yong QJ, et al
    Dynamic changes of pulmonary arterial pressure in perinatal neonates with pulmonary and extrapulmonary acute lung injury/respiratory distress syndrome.
    Medicine (Baltimore). 2019;98:e14830.
    Abstract    

    Abstract available

  45. FARHAT N, Lador F, Beghetti M
    Diagnosis and treatment of pediatric pulmonary arterial hypertension.
    Expert Rev Cardiovasc Ther. 2019;17:161-175.
    Abstract    

    Abstract available

  46. BAN Y, Liu Y, Li Y, Zhang Y, et al
    S-nitrosation impairs KLF4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension.
    Redox Biol. 2019;21:101099.
    Abstract    

    Abstract available

  47. DORNELES RG, Plachi F, Gass R, Toniazzo VT, et al
    Sensory consequences of critical inspiratory constraints during exercise in pulmonary arterial hypertension.
    Respir Physiol Neurobiol. 2019;261:40-47.
    Abstract    

    Abstract available

  48. IMOTO K, Okada M, Yamawaki H
    Periostin Mediates Right Ventricular Failure through Induction of Inducible Nitric Oxide Synthase Expression in Right Ventricular Fibroblasts from Monocrotaline-Induced Pulmonary Arterial Hypertensive Rats.
    Int J Mol Sci. 2018;20.
    Abstract    

    Abstract available

  49. GHANI AR, Hamid M, Dhillon P, Ullah W, et al
    Tilting the balance: hemidiaphragm paralysis leading to right to left cardiac shunt.
    BMJ Case Rep. 2018;11.
    Abstract    

    Abstract available

  50. HAN J, Tian H, Liu Y, Fan F, et al
    Sarpogrelate attenuates pulmonary arterial hypertension via calcium/calcineurin axis.
    Front Biosci (Landmark Ed). 2019;24:607-615.
    Abstract    

    Abstract available

  51. LI J, Zhuang Q, Zhang X, Zheng Y, et al
    Prevalence and Prognosis of Portopulmonary Hypertension in 223 Liver Transplant Recipients.
    Can Respir J. 2018;2018:9629570.
    Abstract    

    Abstract available

  52. HENROHN D, Bjorkstrand K, Lundberg JO, Granstam SO, et al
    Effects of Oral Supplementation With Nitrate-Rich Beetroot Juice in Patients With Pulmonary Arterial Hypertension-Results From BEET-PAH, an Exploratory Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    J Card Fail. 2018;24:640-653.
    Abstract    

    Abstract available

  53. BALMAIN BN, Seale H, Harris J, Hall K, et al
    Relating exercise-induced desaturation and gas-exchange in pulmonary artery hypertension.
    Respir Physiol Neurobiol. 2019;259:58-62.
    Abstract    

    Abstract available

  54. SHI ZL, Fang K, Li ZH, Ren DH, et al
    EZH2 Inhibition Ameliorates Transverse Aortic Constriction-Induced Pulmonary Arterial Hypertension in Mice.
    Can Respir J. 2018;2018:9174926.
    Abstract    

    Abstract available

  55. GONG SG, Wang L, Pudasaini B, Yuan P, et al
    Transition from Ambrisentan to Bosentan in Pulmonary Arterial Hypertension: A Single-Center Prospective Study.
    Can Respir J. 2018;2018:9836820.
    Abstract    

    Abstract available

  56. KIDO T, Nishigaki K, Kawahira Y, Kagisaki K, et al
    Cardiac surgical strategy for extremely low-birthweight infants with pulmonary overcirculation.
    Interact Cardiovasc Thorac Surg. 2018;26:840-844.
    Abstract    

    Abstract available

  57. KUMAR VHS, Wang H, Kishkurno S, Paturi BS, et al
    Long-Term Effects of Neonatal Hyperoxia in Adult Mice.
    Anat Rec (Hoboken). 2018;301:717-726.
    Abstract    

    Abstract available

  58. RAVIKUMAR N, Gooya A, Cimen S, Frangi AF, et al
    Group-wise similarity registration of point sets using Student's t-mixture model for statistical shape models.
    Med Image Anal. 2018;44:156-176.
    Abstract    

    Abstract available

  59. BAUSEWEIN C, Schunk M, Schumacher P, Dittmer J, et al
    Breathlessness services as a new model of support for patients with respiratory disease.
    Chron Respir Dis. 2018;15:48-59.
    Abstract    

    Abstract available

  60. SUGIYAMA K, Suzuki S, Maruno K, Fujiyoshi T, et al
    Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension with active Crohn's disease.
    Surg Case Rep. 2019;5:59.
    Abstract    

    Abstract available

  61. BANDYOPADHYAY D, Devanabanda AR, Hajra A, Tummala R, et al
    Impact of pulmonary hypertension in patients undergoing atrial fibrillation ablation: A nationwide study.
    Int J Cardiol Heart Vasc. 2019;23:100348.
    Abstract    



  62. SHIMODA LA
    CA Dreamin': Carbonic Anhydrase Inhibitors, Macrophages and Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2019 Apr 11. doi: 10.1165/rcmb.2019-0122.
    Abstract    



  63. SUN WL, Wang JL, Jia GH, Mi WJ, et al
    Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease.
    Chin Med J (Engl). 2019 Apr 3. doi: 10.1097/CM9.0000000000000247.
    Abstract    

    Abstract available

  64. UCHIYAMA N, Yuasa T, Miyata M, Horizoe Y, et al
    Correlation of Right Ventricular Wall Stress With Plasma B-Type Natriuretic Peptide Levels in Patients With Pulmonary Hypertension.
    Circ J. 2019 Apr 9. doi: 10.1253/circj.CJ-18-1155.
    Abstract    

    Abstract available

  65. DATT V, Khurana P, Aggarwal S, Mishra S, et al
    Perioperative management of a patient with double orifice mitral valve with supramitral ring with subaortic membrane with ventricular septal defect and severe pulmonary hypertension: Report of a rare case.
    Ann Card Anaesth. 2019;22:215-220.
    Abstract    

    Abstract available

  66. ABDELAZZIZ MM, Abdelhamid HM
    Terlipressin versus norepinephrine to prevent milrinone-induced systemic vascular hypotension in cardiac surgery patient with pulmonary hypertension.
    Ann Card Anaesth. 2019;22:136-142.
    Abstract    

    Abstract available

  67. MELZIG C, Worz S, Egenlauf B, Partovi S, et al
    Combined automated 3D volumetry by pulmonary CT angiography and echocardiography for detection of pulmonary hypertension.
    Eur Radiol. 2019 Apr 8. pii: 10.1007/s00330-019-06188.
    Abstract    

    Abstract available

  68. BERLIER C, Schwarz EI, Saxer S, Lichtblau M, et al
    Real-Life Experience with Selexipag as an Add-On Therapy to Oral Combination Therapy in Patients with Pulmonary Arterial or Distal Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Analysis.
    Lung. 2019 Apr 8. pii: 10.1007/s00408-019-00222.
    Abstract    

    Abstract available

  69. KONDO T, Okumura N, Adachi S, Murohara T, et al
    Editors' Choice Pulmonary Hypertension: Diagnosis, Management, and Treatment.
    Nagoya J Med Sci. 2019;81:19-30.
    Abstract    

    Abstract available

  70. PETRAUSKAS LA, Saketkoo LA, Kazecki T, Saito S, et al
    Use of red cell distribution width in a population at high risk for pulmonary hypertension.
    Respir Med. 2019;150:131-135.
    Abstract    

    Abstract available

  71. AWERBACH JD, Stackhouse KA, Lee J, Dahhan T, et al
    Outcomes of lung disease-associated pulmonary hypertension and impact of elevated pulmonary vascular resistance.
    Respir Med. 2019;150:126-130.
    Abstract    

    Abstract available

  72. ESCRIBANO-SUBIAS P, Bendjenana H, Curtis P, Lang I, et al
    EXPRESS: Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH).
    Pulm Circ. 2019 Apr 8:2045894019846433. doi: 10.1177/2045894019846433.
    Abstract    



  73. FINSTERER J
    Pulmonary hypertension may be secondary in carriers of compound heterozygous FOXRED1 variants.
    Mol Genet Metab Rep. 2019;19:100468.
    Abstract    



  74. HUMBERT M, Galie N, McLaughlin VV, Rubin LJ, et al
    An insider view on the World Symposium on Pulmonary Hypertension.
    Lancet Respir Med. 2019 Apr 4. pii: S2213-2600(19)30111.
    Abstract    



  75. KIM D, George MP
    Pulmonary Hypertension.
    Med Clin North Am. 2019;103:413-423.
    Abstract    

    Abstract available

  76. WANG Y, Dai S, Cheng X, Prado E, et al
    Notch3 signaling activation in smooth muscle cells promotes extrauterine growth restriction-induced pulmonary hypertension.
    Nutr Metab Cardiovasc Dis. 2019 Mar 13. pii: S0939-4753(19)30086.
    Abstract    

    Abstract available

  77. MALAHFJI M, Arain S
    Reversed Pulsus Paradoxus in Right Ventricular Failure.
    Methodist Debakey Cardiovasc J. 2018;14:298-300.
    Abstract    

    Abstract available

  78. YU X, Zhang Y, Luo Q, Liu Z, et al
    Iron deficiency in pulmonary arterial hypertension associated with congenital heart disease.
    Scand Cardiovasc J. 2018;52:378-382.
    Abstract    

    Abstract available

  79. NAITO A, Sakao S, Lang IM, Voelkel NF, et al
    Endothelial cells from pulmonary endarterectomy specimens possess a high angiogenic potential and express high levels of hepatocyte growth factor.
    BMC Pulm Med. 2018;18:197.
    Abstract    

    Abstract available

  80. KHIRFAN G, Tonelli AR, Ramsey J, Sahay S, et al
    Palliative care in pulmonary arterial hypertension: an underutilised treatment.
    Eur Respir Rev. 2018;27.
    Abstract    

    Abstract available

  81. CLERCX C, Fastres A, Roels E
    Idiopathic pulmonary fibrosis in West Highland white terriers: An update.
    Vet J. 2018;242:53-58.
    Abstract    

    Abstract available

  82. AVAZMOHAMMADI R, Mendiola EA, Soares JS, Li DS, et al
    A Computational Cardiac Model for the Adaptation to Pulmonary Arterial Hypertension in the Rat.
    Ann Biomed Eng. 2019;47:138-153.
    Abstract    

    Abstract available

  83. MISUMI K, Ogo T, Ueda J, Tsuji A, et al
    Development of Pulmonary Arterial Hypertension in a Patient Treated with Qing-Dai (Chinese Herbal Medicine).
    Intern Med. 2019;58:395-399.
    Abstract    

    Abstract available

  84. BADAGLIACCA R, Papa S, Poscia R, Pezzuto B, et al
    The importance of right ventricular function in patients with pulmonary arterial hypertension.
    Expert Rev Respir Med. 2018;12:809-815.
    Abstract    

    Abstract available

  85. YORIFUJI K, Uemura Y, Horibata S, Tsuji G, et al
    CHST3 and CHST13 polymorphisms as predictors of bosentan-induced liver toxicity in Japanese patients with pulmonary arterial hypertension.
    Pharmacol Res. 2018;135:259-264.
    Abstract    

    Abstract available

  86. RIBEIRO BAPTISTA B, Petitpain N, Gomez E, Yelehe-Okouma M, et al
    Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine.
    Fundam Clin Pharmacol. 2019;33:127-129.
    Abstract    

    Abstract available

  87. WADA H, Nakajima T, Suzuki H, Anazawa R, et al
    Pulmonary capillary hemangiomatosis diagnosed by pathology of explanted lungs: a unique etiology serves as a key of clinical diagnosis.
    Gen Thorac Cardiovasc Surg. 2019;67:332-335.
    Abstract    

    Abstract available

  88. MAZIMBA S, Welch TS, Mwansa H, Breathett KK, et al
    Haemodynamically Derived Pulmonary Artery Pulsatility Index Predicts Mortality in Pulmonary Arterial Hypertension.
    Heart Lung Circ. 2019;28:752-760.
    Abstract    

    Abstract available

  89. SUNDARAM SM, Chung L
    An Update on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: a Review of the Current Literature.
    Curr Rheumatol Rep. 2018;20:10.
    Abstract    

    Abstract available

  90. DOGAN M, Efe TH, Cimen T, Ozisler C, et al
    Pulmonary Arterial Hemodynamic Assessment by a Novel Index in Systemic Sclerosis Patients: Pulmonary Pulse Transit Time.
    Lung. 2018;196:173-178.
    Abstract    

    Abstract available

  91. CONG LH, Du SY, Wu YN, Liu Y, et al
    Upregulation of Klotho potentially inhibits pulmonary vascular remodeling by blocking the activation of the Wnt signaling pathway in rats with PM2.5-induced pulmonary arterial hypertension.
    J Cell Biochem. 2018;119:5581-5597.
    Abstract    

    Abstract available

  92. MUTLAK D, Lessick J, Khalil S, Yalonetsky S, et al
    Tricuspid regurgitation in acute heart failure: is there any incremental risk?
    Eur Heart J Cardiovasc Imaging. 2018;19:993-1001.
    Abstract    

    Abstract available

  93. COWIE B, Kluger R
    Oesophageal or transgastric views for estimating mean pulmonary artery pressure with transoesophageal echocardiography: A prospective observational study.
    Eur J Anaesthesiol. 2018;35:349-355.
    Abstract    

    Abstract available

  94. SANTOSH S, Chu C, Mwangi J, Narayan M, et al
    Changes in pulmonary artery systolic pressure and right ventricular function in patients with end-stage renal disease on maintenance dialysis.
    Nephrology (Carlton). 2019;24:74-80.
    Abstract    

    Abstract available

  95. DHOBLE S, Patravale V
    Development of anti-angiogenic erlotinib liposomal formulation for pulmonary hypertension: a QbD approach.
    Drug Deliv Transl Res. 2019 Apr 18. pii: 10.1007/s13346-019-00641.
    Abstract    

    Abstract available

  96. FOROUZAN O, Dinges E, Runo JR, Keevil JG, et al
    Exercise-Induced Changes in Pulmonary Artery Stiffness in Pulmonary Hypertension.
    Front Physiol. 2019;10:269.
    Abstract    

    Abstract available

  97. ZHANG H, Chen SL
    Reply: Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist?
    JACC Cardiovasc Interv. 2019;12:800-801.
    Abstract    



  98. YAYLALI YT, Basarici I
    Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist?
    JACC Cardiovasc Interv. 2019;12:799-800.
    Abstract    



  99. BILLINGS CG, Lewis R, Hurdman JA, Condliffe R, et al
    Express: The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry.
    Pulm Circ. 2019 Apr 18:2045894019848649. doi: 10.1177/2045894019848649.
    Abstract    



  100. YOKOKAWA T, Sugimoto K, Nakazato K, Misaka T, et al
    Electrocardiographic Criteria of Right Ventricular Hypertrophy in Patients with Chronic Thromboembolic Pulmonary Hypertension after Balloon Pulmonary Angioplasty.
    Intern Med. 2019 Apr 17. doi: 10.2169/internalmedicine.2320.
    Abstract    

    Abstract available

  101. FU L, Zhang X
    Correlation between changes in brain natriuretic peptide and echocardiographic features in persistent pulmonary hypertension of newborn.
    J Matern Fetal Neonatal Med. 2019 Apr 17:1-5. doi: 10.1080/14767058.2018.1543392
    Abstract    

    Abstract available

  102. LI L, Zhang W, Lin F, Lu X, et al
    Synthesis and biological evaluation of pyrazolo[3,4-b]pyridine-3-yl pyrimidine derivatives as sGC stimulators for the treatment of pulmonary hypertension.
    Eur J Med Chem. 2019;173:107-116.
    Abstract    

    Abstract available

  103. RHINE WD, Suzuki S, Potenziano JL, Escalante S, et al
    An Analysis of Time to Improvement in Oxygenation in Japanese Preterm and Late Preterm or Term Neonates With Hypoxic Respiratory Failure and Pulmonary Hypertension.
    Clin Ther. 2019 Apr 12. pii: S0149-2918(19)30123.
    Abstract    

    Abstract available

  104. KRIECHBAUM SD, Wiedenroth CB, Hesse ML, Ajnwojner R, et al
    Development of renal function during staged balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension.
    Scand J Clin Lab Invest. 2019 Apr 15:1-8. doi: 10.1080/00365513.2019.1601765.
    Abstract    

    Abstract available

  105. MENG H, Chandrasekaran K, Villarraga HR, Shah AA, et al
    Right and left ventricular interaction in pulmonary hypertension: Insight from velocity vector imaging.
    Echocardiography. 2019 Apr 15. doi: 10.1111/echo.14328.
    Abstract    

    Abstract available

  106. MEHTA KS, Shirkande AK, Bhurke SP, Pajai AE, et al
    Pulmonary Hypertension in Various Stages of Chronic Kidney Disease in Indian Patients.
    Indian J Nephrol. 2019;29:95-101.
    Abstract    

    Abstract available

  107. CASCINO T, McLaughlin VV, Richardson C, Behbahani-Nejad N, et al
    EXPRESS: Barriers to physical activity in patients with pulmonary hypertension.
    Pulm Circ. 2019 Apr 15:2045894019847895. doi: 10.1177/2045894019847895.
    Abstract    



  108. YAO Y, Li H, Da X, He Z, et al
    SUMOylation of Vps34 by SUMO1 promotes phenotypic switching of vascular smooth muscle cells by activating autophagy in pulmonary arterial hypertension.
    Pulm Pharmacol Ther. 2019;55:38-49.
    Abstract    

    Abstract available

  109. LIU A, Liu Y, Li B, Yang M, et al
    Role of miR-223-3p in pulmonary arterial hypertension via targeting ITGB3 in the ECM pathway.
    Cell Prolif. 2019;52:e12550.
    Abstract    

    Abstract available

  110. KRISHNAN A, Markham R, Savage M, Wong YW, et al
    Right Heart Catheterisation: How To Do It.
    Heart Lung Circ. 2019;28:e71-e78.
    Abstract    

    Abstract available

  111. ZWIJNENBURG RD, Baggen VJM, Geenen LW, Voigt KR, et al
    The prevalence of pulmonary arterial hypertension before and after atrial septal defect closure at adult age: A systematic review.
    Am Heart J. 2018;201:63-71.
    Abstract    

    Abstract available

  112. DAIZADEH I
    Pulmonary Arterial Hypertension: A Case Study in FDA Expedited Program Designations.
    Ther Innov Regul Sci. 2019;53:264-269.
    Abstract    

    Abstract available

  113. GILLMEYER KR, Lee KM, Shao Q, Miller DR, et al
    Multisystem Healthcare Use among U.S. Veterans with Pulmonary Hypertension.
    Ann Am Thorac Soc. 2019 Apr 26. doi: 10.1513/AnnalsATS.201902.
    Abstract    



  114. PASCOE HM, Pascoe D, McCusker MW, Heinze SB, et al
    Turbulent flow artefact mimicking central pulmonary emboli in pulmonary hypertension: A report of two cases.
    J Med Imaging Radiat Oncol. 2019 Apr 25. doi: 10.1111/1754-9485.12893.
    Abstract    

    Abstract available

  115. SUGIYAMA K, Suzuki S, Fujiyoshi T, Koizumi N, et al
    Extracorporeal membrane oxygenation after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
    J Card Surg. 2019 Apr 24. doi: 10.1111/jocs.14052.
    Abstract    

    Abstract available

  116. LINZ D, Dobrev D
    Outcome of atrial fibrillation ablation in pulmonary hypertension: Is pulmonary hypertension a modifiable risk factor?
    Int J Cardiol Heart Vasc. 2019;23:100360.
    Abstract    



  117. VETESKOVA J, Kmecova Z, Malikova E, Doka G, et al
    Opposite alterations of endothelin-1 in lung and pulmonary artery mirror gene expression of bone morphogenetic protein receptor 2 in experimental pulmonary hypertension.
    Exp Lung Res. 2019 Apr 23:1-12. doi: 10.1080/01902148.2019.1605426.
    Abstract    

    Abstract available

  118. EGAN PC, Liang OD, Goldberg LR, Aliotta JM, et al
    Low dose 100 cGy irradiation as a potential therapy for pulmonary hypertension.
    J Cell Physiol. 2019 Apr 22. doi: 10.1002/jcp.28723.
    Abstract    

    Abstract available

  119. HAJOULI S, Moustafa MA, Memoli JSW
    Pulmonary Veno-Occlusive Disease: A Rare Cause of Pulmonary Hypertension.
    J Investig Med High Impact Case Rep. 2019;7:2324709619840375.
    Abstract    

    Abstract available

  120. WANG L, Zhu X, Zhao LP, Wang M, et al
    Effect of beraprost on pulmonary hypertension due to left ventricular systolic dysfunction.
    Medicine (Baltimore). 2019;98:e14965.
    Abstract    

    Abstract available

  121. CHEN H, Xiang B, Zeng J, Luo H, et al
    The feasibility in estimating pulmonary vascular resistance by cardiovascular magnetic resonance in pulmonary hypertension: A systematic review and meta-analysis.
    Eur J Radiol. 2019;114:137-145.
    Abstract    

    Abstract available

  122. SHARMA S, Fox H, Aguilar F, Mukhtar U, et al
    Positive Airway Pressure Therapy Reduces Pulmonary Hypertension in Patients Admitted for Acute Heart Failure with Pulmonary Hypertension and Obstructive Sleep Apnea. The ASAP-HF Pilot Trial.
    Sleep. 2019 Apr 20. pii: 5475513. doi: 10.1093.
    Abstract    

    Abstract available

  123. JONAS K, Magon W, Podolec P, Kopec G, et al
    Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio and Systemic Inflammation in Patients with Idiopathic Pulmonary Arterial Hypertension.
    Med Sci Monit. 2019;25:746-753.
    Abstract    

    Abstract available

  124. ZHUANG W, Lian G, Huang B, Du A, et al
    CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension.
    Mol Cell Biochem. 2019;455.
    Abstract    

    Abstract available

  125. WANG YD, Li YD, Ding XY, Wu XP, et al
    17beta-estradiol preserves right ventricular function in rats with pulmonary arterial hypertension: an echocardiographic and histochemical study.
    Int J Cardiovasc Imaging. 2019;35:441-450.
    Abstract    

    Abstract available

  126. CHENG XW, Narisawa M, Jin X, Murohara T, et al
    Sirtuin 1 as a potential therapeutic target in pulmonary artery hypertension.
    J Hypertens. 2018;36:1032-1035.
    Abstract    



  127. IBRAHIM U, Saqib A, Dhar V, Odaimi M, et al
    Dasatinib-induced pulmonary arterial hypertension - A rare late complication.
    J Oncol Pharm Pract. 2019;25:727-730.
    Abstract    

    Abstract available

  128. UDJUS C, Cero FT, Halvorsen B, Behmen D, et al
    Caspase-1 induces smooth muscle cell growth in hypoxia-induced pulmonary hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2019 Mar 25. doi: 10.1152/ajplung.00322.2018
    Abstract    

    Abstract available

  129. NISHIHARA T, Yamamoto E, Tokitsu T, Sueta D, et al
    New Definition of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction Patients.
    Am J Respir Crit Care Med. 2019 Mar 27. doi: 10.1164/rccm.201901-0148.
    Abstract    




  130. Erratum: Galectin-3 Promotes Vascular Remodeling and Contributes to Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018;198:824.
    Abstract    



  131. ZABINI D, Granton E, Hu Y, Miranda MZ, et al
    Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition.
    Am J Respir Crit Care Med. 2018;197:244-260.
    Abstract    

    Abstract available

  132. BUDAS GR, Boehm M, Kojonazarov B, Viswanathan G, et al
    ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2018;197:373-385.
    Abstract    

    Abstract available

  133. MERCURIO V, Mukherjee M, Tedford RJ, Zamanian RT, et al
    Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2018;197:388-391.
    Abstract    



  134. WAGNER BD, Babinec AE, Carpenter C, Gonzalez S, et al
    Proteomic Profiles Associated with Early Echocardiogram Evidence of Pulmonary Vascular Disease in Preterm Infants.
    Am J Respir Crit Care Med. 2018;197:394-397.
    Abstract    



  135. ALTSCHUL E, Remy-Jardin M, Machnicki S, Sulica R, et al
    Imaging of pulmonary hypertension: Pictorial essay.
    Chest. 2019 Apr 11. pii: S0012-3692(19)30826-8. doi: 10.1016/j.chest.2019.
    Abstract    

    Abstract available

  136. GUIGNABERT C, Tu L, Feige JJ, Humbert M, et al
    Response by Guignabert et al to Letter Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension".
    Circ Res. 2019;124:e82-e83.
    Abstract    



  137. MORRELL NW, Upton PD, Li W, Yu PB, et al
    Letter by Morrell et al Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension".
    Circ Res. 2019;124:e81.
    Abstract    



  138. RUBIN LJ
    Assessing Prognosis of Pulmonary Arterial Hypertension in the Therapeutic Era: Importance of Serial Hemodynamic Measurements.
    Circulation. 2018;137:705-706.
    Abstract    



  139. HEMNES AR, Brittain EL
    Autonomic Nervous System in Pulmonary Arterial Hypertension: Time to Rest and Digest.
    Circulation. 2018;137:925-927.
    Abstract    



  140. WEATHERALD J, Boucly A, Chemla D, Savale L, et al
    The Prognostic Value of Follow-up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Circulation. 2017 Oct 25. pii: CIRCULATIONAHA.117.029254.
    Abstract    

    Abstract available

  141. MARON BA, Ryan JJ
    A Concerning Trend for Patients With Pulmonary Hypertension in the Era of Evidence-Based Medicine.
    Circulation. 2019;139:1861-1864.
    Abstract    



  142. HUMBERT M, Farber HW, Ghofrani HA, Benza RL, et al
    Risk Assessment in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension.
    Eur Respir J. 2019 Mar 28. pii: 13993003.02004-2018.
    Abstract    

    Abstract available

  143. GIBBS JSR, Torbicki A
    Proposed new pulmonary hypertension definition: is 4 mm(Hg) worth re-writing medical textbooks?
    Eur Respir J. 2019;53.
    Abstract    



  144. HOEPER MM, Humbert M
    The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally!
    Eur Respir J. 2019;53.
    Abstract    



  145. KIM NH, Mayer E
    Pulmonary endarterectomy and the cost of patient refusal.
    Eur Respir J. 2018;52.
    Abstract    



  146. PICHL A, Sommer N, Bednorz M, Seimetz M, et al
    Riociguat for treatment of pulmonary hypertension in COPD - a translational study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.02445-2018.
    Abstract    

    Abstract available

  147. BRENOT P, Jais X, Taniguchi Y, Alonso CG, et al
    French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2019 Apr 25. pii: 13993003.02095-2018.
    Abstract    

    Abstract available

  148. YALTA K, Gurdogan M, Kaya C, Zeybey U, et al
    Serum copeptin: a potential guide to clinical decision-making for congenital shunt closure.
    Heart. 2019;105:499-500.
    Abstract    



  149. ENDE-VERHAAR YM, Meijboom LJ, Kroft LJM, Beenen LFM, et al
    Usefulness of standard computed tomography pulmonary angiography performed for acute pulmonary embolism for identification of chronic thromboembolic pulmonary hypertension: results of the InShape III study.
    J Heart Lung Transplant. 2019 Mar 15. pii: S1053-2498(19)31424.
    Abstract    

    Abstract available

  150. BRAVOS E, Cottin V, Dauphin C, Bouvaist H, et al
    Cancer incidence in patients with pre-capillary pulmonary hypertension.
    J Heart Lung Transplant. 2019 Mar 15. pii: S1053-2498(19)31430.
    Abstract    



  151. HUMPL T, Honjo O, Temple M, de Perrot M, et al
    Pulmonary endarterectomy in a toddler with chronic thromboembolic pulmonary hypertension after Denver shunt.
    J Thorac Cardiovasc Surg. 2019 Mar 2. pii: S0022-5223(19)30553.
    Abstract    



  152. NOLY PE, Piquereau J, Coblence M, Ataam JA, et al
    Right ventricular mitochondrial respiratory function in a piglet model of chronic pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2019 Mar 15. pii: S0022-5223(19)30564.
    Abstract    

    Abstract available

  153. AUGOUSTIDES JG
    Commentary: Mitochondrial targets in the failing right ventricle-multiple opportunities to rescue the right heart in pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2019 Mar 21. pii: S0022-5223(19)30672.
    Abstract    



  154. BAX JJ, Di Carli M, Narula J, Delgado V, et al
    Multimodality imaging in ischaemic heart failure.
    Lancet. 2019;393:1056-1070.
    Abstract    

    Abstract available

  155. ACAR S, Donmez G, Acar RD, Kavlak ME, et al
    Idiopathic Pulmonary Hypertension After Liver Transplantation.
    Transplant Proc. 2019 Feb 8. pii: S0041-1345(18)31722.
    Abstract    

    Abstract available

  156. ZHU S, Zhou M, Wei D, Yang H, et al
    Risk Analysis of Perioperative Death in Lung Transplant Patients With Severe Idiopathic Pulmonary Hypertension.
    Transplant Proc. 2019;51:875-879.
    Abstract    

    Abstract available

  157. LAMBERS C, Kornauth C, Oberndorfer F, Boehm PM, et al
    Mechanism of anti-remodelling action of treprostinil in human pulmonary arterial smooth muscle cells.
    PLoS One. 2018;13:e0205195.
    Abstract    

    Abstract available

  158. POWER AS, Norman R, Jones TLM, Hickey AJ, et al
    Mitochondrial function remains impaired in the hypertrophied right ventricle of pulmonary hypertensive rats following short duration metoprolol treatment.
    PLoS One. 2019;14:e0214740.
    Abstract    

    Abstract available

  159. HOFFMANN-VOLD AM, Weigt SS, Palchevskiy V, Volkmann E, et al
    Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis.
    PLoS One. 2018;13:e0206545.
    Abstract    

    Abstract available

  160. COTTIN V, Avot D, Levy-Bachelot L, Baxter CA, et al
    Identifying chronic thromboembolic pulmonary hypertension through the French national hospital discharge database.
    PLoS One. 2019;14:e0214649.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;